We are live on
!
Find out more
BS
Boenning & Scattergood Portfolio holdings
AUM
$622M
1-Year Est. Return
8.79%
This Fund
S&P 500
This Quarter
Est. Return
+6.19%
1 Year Est. Return
-8.79%
3 Year Est. Return
+34.52%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$574M
AUM Growth
+$48.9M
(+9.3%)
Cap. Flow
+$18.8M
Cap. Flow
% of AUM
3.27%
Top 10 Holdings %
Top 10 Hldgs %
23.38%
Holding
387
New
26
Increased
148
Reduced
108
Closed
13
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Schwab Short-Term US Treasury ETF
SCHO
|
+$14.4M |
| 2 |
Artesian Resources
ARTNA
|
+$1.71M |
| 3 |
Citigroup
C
|
+$1.11M |
| 4 |
IBM
IBM
|
+$889K |
| 5 |
Ballast Small/Mid Cap ETF
MGMT
|
+$829K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$999K |
| 2 |
Automatic Data Processing
ADP
|
+$933K |
| 3 |
RAD
Rite Aid Corporation
RAD
|
+$782K |
| 4 |
CVS Health
CVS
|
+$741K |
| 5 |
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
|
+$698K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.18% |
| 2 | Healthcare | 14.64% |
| 3 | Financials | 10.82% |
| 4 | Industrials | 8.7% |
| 5 | Consumer Discretionary | 7.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Microsoft
MSFT
$2.83T
| $25.1M | 4.37% |
92,653
-858
| -0.9% | -$218K |
|
2
Apple
AAPL
$4.72T
| $22.7M | 3.96% |
165,878
-4,363
| -3% | -$565K |
|
3
Johnson & Johnson
JNJ
$623B
| $14.7M | 2.56% |
89,325
-817
| -0.9% | -$135K |
|
|
4
Schwab Short-Term US Treasury ETF
SCHO
$12.7B
| $14.4M | 2.51% |
+562,742
| New | +$14.4M |
|
5
JPMorgan Chase
JPM
$925B
| $11M | 1.91% |
70,693
-182
| -0.3% | -$28.6K |
|
6
Home Depot
HD
$325B
| $10.3M | 1.79% |
32,292
-554
| -2% | -$176K |
|
7
Berkshire Hathaway Class B
BRK.B
$1.06T
| $9.96M | 1.73% |
35,828
-500
| -1% | -$140K |
|
8
AbbVie
ABBV
$454B
| $9.79M | 1.71% |
86,955
+3,100
| +4% | +$349K |
|
9
PepsiCo
PEP
$184B
| $8.63M | 1.5% |
58,231
+60
| +0.1% | +$8.74K |
|
10
Verizon
VZ
$184B
| $7.62M | 1.33% |
136,047
-582
| -0.4% | -$33.4K |
|
11
Abbott
ABT
$175B
| $6.48M | 1.13% |
55,864
+3,022
| +6% | +$352K |
|
|
12
CVS Health
CVS
$136B
| $6.46M | 1.13% |
77,454
-9,048
| -10% | -$741K |
|
13
Amazon
AMZN
$2.52T
| $6.46M | 1.13% |
37,560
+1,860
| +5% | +$309K |
|
14
Alphabet (Google) Class C
GOOG
$3.91T
| $6.19M | 1.08% |
49,360
-400
| -0.8% | -$47.7K |
|
15
Procter & Gamble
PG
$341B
| $6.04M | 1.05% |
44,796
+73
| +0.2% | +$9.88K |
|
|
16
IBM
IBM
$195B
| $5.72M | 1% |
40,809
+6,502
| +19% | +$889K |
|
17
United Parcel Service
UPS
$97.4B
| $5.66M | 0.99% |
27,222
+67
| +0.2% | +$13.4K |
|
18
McDonald's
MCD
$187B
| $5.57M | 0.97% |
24,091
-598
| -2% | -$139K |
|
19
Walt Disney
DIS
$161B
| $5.55M | 0.97% |
31,557
-403
| -1% | -$72.5K |
|
20
Becton Dickinson
BDX
$42.1B
| $5.47M | 0.95% |
23,056
+2,255
| +11% | +$541K |
|
21
Essential Utilities
WTRG
$11.2B
| $5.39M | 0.94% |
118,019
-11,579
| -9% | -$543K |
|
22
Cisco
CSCO
$446B
| $4.97M | 0.86% |
93,696
+3,250
| +4% | +$171K |
|
23
ExxonMobil
XOM
$653B
| $4.78M | 0.83% |
75,795
+7,220
| +11% | +$431K |
|
24
Bank of America
BAC
$428B
| $4.75M | 0.83% |
115,333
-250
| -0.2% | -$10.2K |
|
25
Pfizer
PFE
$142B
| $4.64M | 0.81% |
118,534
-3,412
| -3% | -$133K |
|
Similar funds
AAM
F
GBS
C
FPCM
TC
SAS
PIM
Boenning & Scattergood's Q2 2021 Portfolio in Review
As of Q2 2021, Boenning & Scattergood held 387 positions worth $574M, up 9.3% from $525M the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Boenning & Scattergood deployed $18.8M of net new capital in Q2 2021, opening 26 new positions and adding to 148 existing holdings. Its largest new stake was Schwab Short-Term US Treasury ETF: 562,742 shares worth $14.4M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Gilead Sciences, an estimated $999K trimmed.
- Boenning & Scattergood's largest Q2 2021 buy was Schwab Short-Term US Treasury ETF: 562,742 shares worth $14.4M.
- Boenning & Scattergood added most to Artesian Resources in Q2 2021, an estimated $1.71M increase.
- Boenning & Scattergood's biggest Q2 2021 reduction was Gilead Sciences, cutting an estimated $999K.
- Boenning & Scattergood fully exited Rite Aid Corporation in Q2 2021, selling an estimated $782K.
- Boenning & Scattergood's ten largest holdings make up 23% of its $574M portfolio in Q2 2021.
- Boenning & Scattergood opened 26 new positions and closed 13 in Q2 2021.
- Boenning & Scattergood's portfolio value rose 9.3% quarter-over-quarter to $574M.
Based on Boenning & Scattergood's 13F filing for Q2 2021, filed 21 Jul 2021.